Tumour Marker

CA-125 Test (Cancer Antigen 125)

CA-125 is a protein measured in the blood that is best known for its role in ovarian cancer care. A raised result causes understandable anxiety, but many benign conditions raise it too, and the number’s trend matters far more than any single reading.

Written by Suman Konda, Clinical Pharmacist · Based on peer-reviewed sources · Editorial policy · Not medical advice

Last reviewed and updated: 26 September 2026 · How we check our content

Quick answer

CA-125 is a blood marker used mainly to monitor ovarian cancer; normal is below 35 U/mL. A raised result does not mean cancer: endometriosis, fibroids, menstruation and pregnancy commonly raise it. Equally, a normal result does not rule cancer out. Doctors track the trend across serial tests from the same lab, not any single reading.

The short answer

CA-125 is a blood marker used mainly to monitor ovarian cancer treatment and recurrence. Normal is below 35 U/mL. Many benign conditions, endometriosis, fibroids, menstruation, also raise it, so a high result does not mean cancer. Equally, a normal result does not rule cancer out. Doctors track how the number moves over time.

What is a CA-125 test?

CA-125 (cancer antigen 125, also called MUC16) is a protein found on the surface of many cells, including the lining of the abdomen and pelvis. When those linings are irritated, by cancer, but also by inflammation, endometriosis or even menstruation, CA-125 sheds into the blood, where a simple blood test can measure it in units per millilitre (U/mL).

Doctors order CA-125 when ovarian cancer is suspected (for example, with a pelvic mass on ultrasound), to monitor response during ovarian cancer treatment, and to watch for recurrence after treatment ends. It is also sometimes raised in cancers of the uterus, fallopian tubes, pancreas and lung, but it is not specific to any of them.

CA-125 Normal Range

CA-125 Level (U/mL)	Interpretation	Typical Next Step
Below 35	Normal range	Routine follow-up
35 – 65	Borderline / mildly raised	Repeat test; check for benign causes
65 – 200	Moderately raised	Imaging + specialist review
Above 200	Markedly raised	Urgent oncology referral

The 35 U/mL cutoff was set to include 99% of healthy people, so by design about 1% of healthy women sit just above it. Levels tend to run lower after menopause. As with all tumour markers, serial results from the same laboratory matter more than any single number, because assay methods differ.

What does HIGH CA-125 mean?

HIGH CA-125 above 35 U/mL

A raised CA-125 is a signal, not a diagnosis. Benign causes are common and include endometriosis, uterine fibroids, menstruation, pregnancy, pelvic inflammatory disease, liver cirrhosis and recent abdominal surgery, any irritation of the abdominal lining can push it up. About 80% of advanced ovarian cancers show an elevated CA-125, and values above 200 are unlikely to be benign, which is why markedly raised results trigger urgent imaging and gynaecologic oncology referral. The level alone never confirms cancer; ultrasound, CT and sometimes surgery are needed to find the cause.

A normal result does not rule out cancer

Normal CA-125, still possible cancer

Roughly half of early-stage ovarian cancers have a completely normal CA-125, and about one in five advanced ovarian cancers never raises it at all. Some tumour types simply do not produce the protein. This is exactly why guidelines do not recommend CA-125 as a screening test for women at average risk: it would miss many early cancers while alarming many healthy women. If symptoms such as persistent bloating, pelvic pain, feeling full quickly or needing to urinate urgently continue, they deserve investigation regardless of a normal CA-125.

How CA-125 is used in ovarian cancer care

Where CA-125 truly earns its place is in monitoring. Once a baseline is established before treatment, a falling level during chemotherapy suggests the treatment is working; a level that stays high or climbs suggests it is not. After treatment ends, regular CA-125 checks can detect recurrence months before symptoms or scans would, a rising trend in a previously treated patient is taken seriously even when the absolute number is still modest.

In all of these uses, the trend is the message. Doctors compare each new result to the patient’s own baseline from the same lab, because switching assay methods can shift the numbers without any real change in disease.

Questions to ask your doctor

What is the most likely cause of my raised CA-125 in my situation?
Do I need a pelvic ultrasound or a referral to a gynaecologic oncologist?
When should we repeat the test, and should it be at the same lab?
Are there benign explanations, endometriosis, fibroids, my cycle, we should check first?

CA-125 vs ultrasound vs HE4: how they compare

CA-125 is the best-known ovarian cancer marker, but it was never meant to be used alone. Each tool answers a different question:

Test	What it measures	When it is ordered	Key limitation
CA-125	A protein raised in many ovarian cancers — and in benign conditions	Monitoring known ovarian cancer, investigating a pelvic mass	Not a screening test: too many false positives in healthy women, and some cancers don't raise it
Transvaginal ultrasound	The ovaries seen directly	First-line investigation of pelvic symptoms or a raised CA-125	Finds lumps but can't always say benign from malignant — needs the clinical picture
HE4 / ROMA	A newer marker, sometimes combined with CA-125	Refining risk when a pelvic mass is found	Less widely available; still a risk estimate, not a diagnosis
CEA	A broader tumour marker	Occasionally in the workup mix	Even less specific — raised in smokers and several benign conditions

CA-125 plus imaging is the standard pairing — the marker tracks, the scan sees.

Reading your report: what your doctor actually looks at

When a doctor opens a CA-125 result, the number itself is only the starting point. Here is the checklist they run through — and the same checklist helps you read your own report calmly:

Why was it ordered? CA-125 for monitoring known ovarian cancer is a different test, interpretively, from CA-125 ordered “just to check.” Screening use in healthy women is not recommended — the context changes everything.
What is the trend? In treated ovarian cancer, falling CA-125 is reassuring and rising CA-125 prompts review. A single value matters far less than the direction of travel.
Could it be benign? Endometriosis, fibroids, menstruation, pregnancy, pelvic infection and even liver disease can all raise CA-125. A raised value in a premenopausal woman has a long benign list.
What does imaging show? The marker is always matched to ultrasound or CT findings — a raised CA-125 with normal imaging is a very different situation from a raised CA-125 with a mass.
Was it the same lab? CA-125 assays differ, so serial values should come from the same laboratory to keep the trend honest.

A raised CA-125 is frightening, but in the absence of a known cancer it is more often benign than malignant — especially before menopause. The next step is imaging and specialist review, not conclusions. Discuss the full picture with your doctor.

CA-125 test price in India: typical bands across major lab chains

CA-125 is a specialised tumour-marker assay. Typical list-price bands:

Lab chain	Typical price band	Notes
Dr Lal PathLabs	Typically &rupee;1,000–&rupee;1,800	Wide network; online booking often slightly cheaper
Metropolis Healthcare	Typically &rupee;900–&rupee;1,700	Frequent online discounts
Thyrocare (via partner labs)	Typically &rupee;900–&rupee;1,500	Often the lowest list price; home collection available
Apollo 24\|7	Typically &rupee;950–&rupee;1,700	Integrated with Apollo hospitals
Orange Health	Typically &rupee;1,000–&rupee;1,800	Home-collection focused in metro cities

These are approximate bands, not quotes: prices change often and vary by city, and home collection can add a small fee. Where possible, choose a NABL-accredited lab, and remember the reference range printed on your own report is the one that counts.

Frequently Asked Questions

What is the normal range for CA-125?

The widely accepted normal range for CA-125 is below 35 U/mL. Values up to about 65 may be considered borderline, while levels above 200 are unlikely to be from a benign cause.

Does a high CA-125 always mean ovarian cancer?

No. Many benign conditions raise CA-125, including endometriosis, uterine fibroids, menstruation, pregnancy, pelvic infection and liver disease. A high result needs imaging and specialist review, not panic.

Can CA-125 be normal with ovarian cancer?

Yes. About half of early-stage ovarian cancers have a normal CA-125, and roughly 20% of advanced cases never raise it. That is why CA-125 is not used as a general screening test.

Why is CA-125 tested repeatedly?

The trend matters more than any single value. A falling CA-125 during treatment suggests the therapy is working, while a rising level after treatment can be the earliest sign of recurrence.

Should every woman get a CA-125 test?

No. Guidelines do not recommend CA-125 screening for women at average risk, because false alarms are common and it misses many early cancers. It is mainly used when ovarian cancer is suspected or already diagnosed.

How much does the CA-125 test cost in India?

The CA-125 test typically costs ₹900–₹1,800 in India, though prices vary by city and lab. Choose a NABL-accredited lab where possible — and remember the reference range printed on your own report is the one that counts. Discuss the result with your doctor.

Pharmacist's practical notes

CA-125's reputation as “the ovarian cancer test” does it a disservice: it is a monitoring tool that got mistaken for a screening test. Ordered without a reason, it produces far more anxiety than answers — raised by endometriosis, fibroids, even menstruation. If yours was ordered “just to check,” the most useful question for your doctor is what the result would change.

During treatment for known ovarian cancer, the trend is the message: falling values reassure, rising values prompt review. Keep every report from the same lab, in order — the trend line is the clinical tool, not any single number.

In India

Indian labs usually report CA-125 in U/mL. The test typically costs &rupee;900–&rupee;1,800, though prices vary by city and lab.

Where possible, choose a NABL-accredited lab. Assays differ between labs, so serial values should come from the same laboratory.

Should I get CA-125 as a routine cancer screen?

No. It is not recommended for screening women without symptoms or risk factors — too many benign conditions raise it, which leads to anxiety and unnecessary procedures. It is a monitoring tool, not a screening one.

My CA-125 is slightly high but I feel fine. Should I worry?

Mild rises are commonly benign — fibroids, endometriosis, and menstruation are frequent causes. Doctors usually repeat the test and investigate calmly rather than acting on one value. Discuss it with your doctor instead of worrying alone.

Can my period affect CA-125?

Yes — menstruation can raise CA-125. If possible, avoid testing during your period, and always tell the lab where you are in your cycle so the result is read in context.

What CA-125 level is concerning?

There is no single alarming number: labs commonly flag above 35 U/mL, but interpretation depends on menopausal status, symptoms, and above all the trend across repeat tests. Your doctor reads it as part of the whole picture.

Medical Disclaimer: This page is for general educational purposes only and does not constitute medical advice. Always consult a qualified doctor before making any health decisions.